The purpose of long-term incentive plans is to generate the conditions for retaining and recruiting competent personnel to the Group and to offer employees an attractive opportunity to acquire a stake in the company, so as to encourage continued company loyalty by combining the interests of the shareholders and the employees.The programmes are thought to have a positive effect on the Group’s ongoing development and hence to be beneficial for shareholders and the company alike.
According to an AGM resolution, the Nomination Committee 2022-2023 should consist of representatives of at least the three largest shareholders at the end of the third quarter of 2022 and the Chairman of the Board. Work on composing the Nomination Committee is now completed, and this year’s Nomination Committee consists of:
Karl Tobieson (Chairman), appointed by Linc AB
Richard Torgerson, appointed by Nordea Investment Funds
Anders Hallberg, appointed by HealthInvest Partners
Uli Hacksell, Chairman of the Board, Medivir AB
Remuneration principles for senior executives of Medivir are determined by the Annual General Meeting. The term, senior executives, refers to the CEO and other members of the management group.
The guidelines mean, in effect, that the company shall offer a competitive total remuneration package that enables the recruitment and retention of qualified senior executives.
See the profiles of our management team and Board of Directors